SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): March 25, 2013
Amarin Corporation plc
(Exact name of registrant as specified in its charter)
|England and Wales||0-21392||Not applicable|
(State or other jurisdiction
2 Pembroke House, Upper Pembroke Street 28-32, Dublin 2,
|(Address of principal executive offices)||(Zip Code)|
Registrants telephone number, including area code: +353 1 6699 020
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|¨||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|¨||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|¨||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|¨||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) Retirement of Joseph Anderson and Carl Gordon
As disclosed in the Preliminary Proxy Statement of Amarin Corporation plc (the Company) filed on March 25, 2013, on March 25, 2013, each of Dr. Joseph Anderson and Dr. Carl Gordon informed the Board of Directors of his intention to not stand for re-election at, and his resignation from office effective immediately after, the Companys annual general meeting of shareholders in 2013, which is currently scheduled for July 9, 2013. Each of Dr. Anderson and Dr. Gordon is expected to continue to serve through, and retire immediately following, the close of the Companys annual general meeting of shareholders in 2013. The decisions of Dr. Anderson and Dr. Gordon to not stand for re-election did not involve any disagreement with the Company.
* * *
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|Date: March 28, 2013||Amarin Corporation plc|